Cancer and Oncology Terms

A substance that is being studied in the treatment of cancer.

A family of anticancer drugs that interfere with the growth of tumor cells by blocking the formation of deoxyribonucleotides (building blocks of DNA).

A rare condition in which chronic lymphocytic leukemia (CLL) changes into a fast-growing type of lymphoma.

A slow leukemia that has been quiet for years turning abruptly into an aggressive lymphoma, usually announced by one rapidly swelling node.

Stripping out B cells treats both a cancer of those cells and diseases in which the same cells drive an attack on the body.

Because CD20 is absent from stem cells and from antibody-producing plasma cells, the B cell population rebuilds and existing immunity is largely kept.

A substance that is being studied in the prevention of oral mucositis in patients receiving radiation therapy or chemotherapy for head and neck cancer.

A substance that is being studied in the treatment of cancer.

A substance that is being studied in the treatment of anemia in patients who are receiving chemotherapy.

A substance being studied in the treatment of cancer.

A drug designed to fix one problem that created a larger one, and much of the reason anti-inflammatories now carry heart warnings.

A substance being studied in the treatment of cancer.

The active ingredient in a drug that helps control the amount of glucose (sugar) in the blood and is being studied in the prevention and treatment of some types of cancer.

A drug that helps control the amount of glucose (sugar) in the blood and is being studied in the prevention and treatment of some types of cancer.

An abbreviation for a chemotherapy combination used with other types of therapy to treat colorectal cancer.

A substance being studied in the treatment of cancer.

A substance that is being studied in the treatment of cancer.

A drug that is used to treat many types of cancer and is being studied in the treatment of other types of cancer.

A cancer vaccine made with a form of a vaccinia virus that does not cause disease in humans.

A measure of the percentage of cells in a tumor that are in the phase of the cell cycle during which DNA is synthesized.